While this is sometimes acceptable for short periods, tirzepatide stability in a drawn syringe is not the same as stability in the original vial
Concerns could include underdosing, lack of clinical data on microdosing, and patients making decisions without guidance, Tebra researchers concluded
The trials were conducted at 536 sites in 33 countries, including Canada, Mexico, Russia, Ukraine, Turkey, India, South Africa, Japan, Hong Kong, multiple European countries, Argentina, and the United States
We are conveniently located at 5748 N Canton Center Rd, Canton Township, MI 48187
In Quebec, where one in four adults is obese, the current cost of these new drugs (approximately $500 per month) would involve an annual expenditure of several hundred million dollars (in the United States the situation is even worse: the cost of a 72-week course of tirzepatide (15 mg/week) is approximately US$17,000, while the 68-week treatment with semaglutide (2.4 mg/week) is nearly US$23,000!)